Barclays’s BioAtla BCAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-6
| Closed | – | – | 4346 |
|
|
2025
Q1 | $0 | Buy |
+6
| New | – | ﹤0.01% | 4377 |
|
|
2024
Q3 | – | Sell |
-566
| Closed | – | – | 4318 |
|
|
2024
Q2 | $0 | Sell |
566
-30,636
| -98% | – | ﹤0.01% | 4176 |
|
|
2024
Q1 | $107K | Sell |
31,202
-29,691
| -49% | -$102K | ﹤0.01% | 3617 |
|
|
2023
Q4 | $149K | Buy |
60,893
+52,950
| +667% | +$130K | ﹤0.01% | 3610 |
|
|
2023
Q3 | $14K | Sell |
7,943
-884
| -10% | -$1.56K | ﹤0.01% | 3968 |
|
|
2023
Q2 | $27K | Buy |
+8,827
| New | +$27K | ﹤0.01% | 3906 |
|
|
2023
Q1 | – | Sell |
-37,339
| Closed | -$308K | – | 4298 |
|
|
2022
Q4 | $308K | Buy |
37,339
+35,463
| +1,890% | +$293K | ﹤0.01% | 2877 |
|
|
2022
Q3 | $14K | Buy |
1,876
+481
| +34% | +$3.59K | ﹤0.01% | 4054 |
|
|
2022
Q2 | $4K | Sell |
1,395
-65,291
| -98% | -$187K | ﹤0.01% | 4499 |
|
|
2022
Q1 | $333K | Buy |
+66,686
| New | +$333K | ﹤0.01% | 3037 |
|